Insulin antibody responses with insulin lispro in long term studies in patients with type 1 or type 2 diabetes

被引:0
|
作者
Brunelle, RL
Huang, J
Fineberg, SE
Anderson, JH
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
358
引用
收藏
页码:A98 / A98
页数:1
相关论文
共 50 条
  • [21] Treatment of type 1 diabetes with insulin lispro during Ramadan
    Al-Nakhi, A
    Kadiri, A
    El-Ghazali, S
    Jabbar, A
    AL Arouj, M
    Akram, J
    Wyatt, J
    Assem, A
    Ristic, S
    DIABETES, 2000, 49 : A352 - A353
  • [22] INSULIN LISPRO WITH CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IS SAFE AND EFFECTIVE IN PATIENTS WITH TYPE 2 DIABETES: A RANDOMIZED CROSSOVER TRIAL OF INSULIN LISPRO VERSUS INSULIN ASPART
    Thrasher, James
    Bhargava, Anuj
    Rees, Tina M.
    Wang, Tao
    Guzman, Cristina B.
    Glass, Leonard C.
    ENDOCRINE PRACTICE, 2015, 21 (03) : 247 - 257
  • [23] Technosphere® Insulin vs Insulin Lispro in Patients with Type 1 Diabetes Using Multiple Daily Injections
    Garg, Satish K.
    McGill, Janet B.
    Rosenstock, Julio
    Hirsch, Irl B.
    Petrucci, Richard E.
    Chang, Ping-Chung
    Boss, Anders H.
    Richardson, Peter C.
    Skyler, Jay S.
    DIABETES, 2011, 60 : A250 - A250
  • [24] Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes
    Pfutzner, A
    Kustner, E
    Forst, T
    SchulzeSchleppinghoff, B
    Trautmann, ME
    Haslbeck, M
    Schatz, H
    Beyer, J
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1996, 104 (01) : 25 - 30
  • [25] Biokinetics of oral spray insulin: comparison with regular and lispro insulin in patients with Type 1 diabetes.
    Manfrini, S
    Coppolino, G
    Costanza, F
    Modi, P
    Montemari, A
    Pozzilli, P
    DIABETOLOGIA, 2002, 45 : A262 - A262
  • [26] Long-term effectiveness of insulin lispro in subjects with type 1 diabetes and basal-prandial regimen
    Hermans, MP
    Schmitt, H
    Buysschaert, M
    DIABETES, 2002, 51 : A472 - A472
  • [27] Insulin lispro reduces insulin antibodies in a patient with type 2 diabetes with immunological insulin resistance
    Asai, M
    Kodera, T
    Ishizeki, K
    Uebori, S
    Kashiwaya, T
    Itoh, H
    Makino, I
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2003, 61 (02) : 89 - 92
  • [28] Treatment of type 1 diabetes with insulin lispro during Ramadan
    Kadiri, A
    Al-Nakhi, A
    El-Ghazali, S
    Jabbar, A
    Al Arouj, M
    Akram, J
    Wyatt, J
    Assem, A
    Ristic, S
    DIABETES & METABOLISM, 2001, 27 (04): : 482 - 486
  • [29] Optimal administration of lispro insulin in hyperglycemic type 1 diabetes
    Rassam, AG
    Zeise, TM
    Burge, MR
    Schade, DS
    DIABETES CARE, 1999, 22 (01) : 133 - 136
  • [30] The disposition of insulin lispro in patients with type 2 diabetes and impaired renal function
    Johnson, RD
    Holcombe, JH
    Seger, M
    Cronin, J
    DIABETES, 1998, 47 : A91 - A91